Aceto Corp (NASDAQ:ACET) Stock Price While Sentiment Dive

Sentiment for Aceto Corp (NASDAQ:ACET)

Aceto Corp (NASDAQ:ACET) institutional sentiment decreased to 0.7 in Q2 2018. Its down -0.79, from 1.49 in 2018Q1. The ratio turned negative, as 45 funds increased and started new positions, while 64 trimmed and sold positions in Aceto Corp. The funds in our partner’s database now possess: 17.09 million shares, down from 21.41 million shares in 2018Q1. Also, the number of funds holding Aceto Corp in their top 10 positions was flat from 0 to 0 for the same number . Sold All: 30 Reduced: 34 Increased: 23 New Position: 22.

Aceto Corporation, together with its subsidiaries, sources, markets, sells, and distributes finished dosage form generics, nutraceutical products, pharmaceutical intermediates and active ingredients, agricultural protection products, and specialty chemicals. The company has market cap of $46.20 million. The firm operates in three divisions: Human Health, Pharmaceutical Ingredients, and Performance Chemicals. It currently has negative earnings. The Human Health segment supplies raw materials used in the production of nutritional and packaged dietary supplements, including vitamins, amino acids, iron compounds, and bio chemicals used in pharmaceutical and nutritional preparations.

The stock decreased 1.96% or $0.03 during the last trading session, reaching $1.5. About 218,529 shares traded. Aceto Corporation (NASDAQ:ACET) has declined 71.48% since December 7, 2017 and is downtrending. It has underperformed by 87.10% the S&P500.

Indexiq Advisors Llc holds 0.03% of its portfolio in Aceto Corporation for 287,814 shares. A.R.T. Advisors Llc owns 45,845 shares or 0.01% of their US portfolio. Moreover, Bluecrest Capital Management Ltd has 0.01% invested in the company for 166,947 shares. The British Columbia – Canada-based Connor Clark & Lunn Investment Management Ltd. has invested 0.01% in the stock. Element Capital Management Llc, a New York-based fund reported 120,535 shares.

Since January 1, 0001, it had 0 insider purchases, and 15 sales for $131,986 activity.

More notable recent Aceto Corporation (NASDAQ:ACET) news were published by: Seekingalpha.com which released: “Dividends By The Numbers For May 2018 – Seeking Alpha” on June 05, 2018, also Seekingalpha.com with their article: “Snapshot Of Cumulative Dividend Cuts In Q2 2018 – Seeking Alpha” published on May 22, 2018, Nasdaq.com published: “Health Care Sector Update for 11/09/2018: JAZZ,ACRX,ACET,NTRA – Nasdaq” on November 09, 2018. More interesting news about Aceto Corporation (NASDAQ:ACET) were released by: Globenewswire.com and their article: “ACETO Reports Fiscal 2018 Third Quarter Results Nasdaq:ACET – GlobeNewswire” published on May 03, 2018 as well as Globenewswire.com‘s news article titled: “ACETO Corporation Adopts Rights Plan Designed to Preserve Valuable Net Operating Loss Carryforwards and Other Tax Benefits – GlobeNewswire” with publication date: November 05, 2018.

Aceto Corporation (NASDAQ:ACET) Institutional Positions Chart

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.